2016
DOI: 10.1107/s205252061600127x
|View full text |Cite
|
Sign up to set email alerts
|

An exceptional 5:4 enantiomeric structure

Abstract: The only crystals that could be grown from racemic solutions of the PF6(-) salt of the resolvable cation [Ru(2,9-dimethyl-1,10-phenanthroline)2(dipyrido[3,2-d:2',3'-f]quinoxaline)](2+) have translational symmetry only (space group P1), contain nine independent sets of ions, and include numerous independent solvent molecules (11 acetone, one diethyl ether and possibly several water molecules). Layers of hydrophobic cations alternate with layers containing most of the anions and solvent molecules. All nine catio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 44 publications
0
7
0
Order By: Relevance
“…That is why it does not encompass compounds containing solvent molecules. For example, E. Wachter et al 96 recently described the crystal structure of a PF 6…”
Section: Systematization Of Discrete Compounds Formed In Binary Chiramentioning
confidence: 99%
See 1 more Smart Citation
“…That is why it does not encompass compounds containing solvent molecules. For example, E. Wachter et al 96 recently described the crystal structure of a PF 6…”
Section: Systematization Of Discrete Compounds Formed In Binary Chiramentioning
confidence: 99%
“…According to statistical data, 96 the occurrence of nonequimolar discrete compounds among substances with chiral molecules is negligible, being 1 : 100 000. If so, is their study practical?…”
Section: Heteromolecular Compounds 1 : Nmentioning
confidence: 99%
“…As these tablets are intended for oral dosage, the solubility of the active pharmaceutical ingredient in the gastric environment (in both thermodymamic and kinetic aspects) may then be affected by a number of physicochemical parameters, including crystal form, morphology, crystal size, degree of crystallinity, and intergrain interactions with excipients and the environment. This is particularly relevant for molecules showing non-interconverting enantiomers (here, of the atropoisomeric type), which, though being processed as 1:1 racemic forms, may further crystallize as a conglomerate of enantiomorphic crystals or even as unbalanced racemates . Thus, starting from material preparation, isolation, processing, and formulation, up to chemical and thermal stability, bioavailability, and pharmacokinetic issues, the strict control of the solid state molecular aggregation type becomes a fundamental question to be answered, particularly when the number of crystal forms is large, and the pertinent energy landscape is highly corrugated.…”
Section: Introductionmentioning
confidence: 99%
“…Based on previous experience in this laboratory (e.g. Koutentis et al, 2001;Bakus et al, 2013;Hao et al, 2005;Wachter et al, 2016) it seemed likely that both frustration and nucleation can be important factors but that the diversity of high-Z 0 structures is too great to allow for any broad generalizations.…”
Section: Introductionmentioning
confidence: 99%